Capital-Force ETF Trust - CapForce IBD 50 ETF
US ˙ ARCA

SecurityFFTY / Capital-Force ETF Trust - CapForce IBD 50 ETF
InstitutionIHT Wealth Management, LLC
Latest Disclosed Ownership48,204 shares
Latest Disclosed Value $ 1,610,491
IHT Wealth Management, LLC reports 0.86% increase in ownership of FFTY / Capital-Force ETF Trust - CapForce IBD 50 ETF

On May 15, 2026 - IHT Wealth Management, LLC filed a 13F-HR form disclosing ownership of 48,204 shares of Capital-Force ETF Trust - CapForce IBD 50 ETF (US:FFTY) valued at $1,610,496 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 47,794 shares of Capital-Force ETF Trust - CapForce IBD 50 ETF. This represents a change in shares of 0.86% during the quarter. The current value of the position is $2,038,547 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 48,204 410 0.86 1,610 -3.19 0.0373
2026-02-17 2025-12-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 47,794 152 0.32 1,664 -6.52 0.0404
2025-11-14 2025-09-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 47,642 -346 -0.72 1,780 14.11 0.0450
2025-08-14 2025-06-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 47,988 -6,974 -12.69 1,559 5.20 0.0429
2025-05-15 2025-03-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 54,962 10,758 24.34 1,482 17.34 0.0463
2025-02-14 2024-12-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 44,204 -22,484 -33.72 1,264 -29.16 0.0408
2024-11-14 2024-09-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 66,688 27,637 70.77 1,784 64.48 0.0506
2024-08-14 2024-06-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 39,051 4,422 12.77 1,084 13.27 0.0404
2024-05-15 2024-03-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 34,629 519 1.52 957 15.16 0.0384
2024-02-14 2023-12-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 34,110 -37 -0.11 831 8.77 0.0371
2023-11-14 2023-09-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 34,147 -765 -2.19 764 -14.45 0.0387
2023-08-15 2023-06-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 34,912 9,614 38.00 893 49.33 0.0465
2023-05-15 2023-03-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 25,298 2,985 13.38 598 23.05 0.0341
2023-02-15 2022-12-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 22,313 -2,749 -10.97 487 -20.72 0.0306
2022-11-22 2022-09-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 25,062 13,017 108.07 613 89.78 0.0466
2022-08-15 2022-06-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 12,045 852 7.61 323 -26.26 0.0285
2022-05-16 2022-03-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 11,193 685 6.52 438 -9.13 0.0332
2022-02-14 2021-12-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 10,508 430 4.27 482 1.05 0.0355
2021-11-15 2021-09-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 10,078 -460 -4.37 477 -2.25 0.0388
2021-08-16 2021-06-30 13F INNOVATOR ETFS TR IBD 50 ETF IBD 50 ETF 45782C102 10,538 347 3.40 488 9.17 0.0309
2021-05-18 2021-03-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 10,191 -272 -2.60 447 3.95 0.0322
2021-02-17 2020-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 10,463 124 1.20 430 11.40 0.0357
2020-11-19 2020-09-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 10,339 -5,134 -33.18 386 -27.58 0.0387
2020-08-14 2020-06-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 15,473 850 5.81 533 30.32 0.0730
2020-05-13 2020-03-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 14,623 -824 -5.33 409 -23.69 0.0589
2020-02-18 2019-12-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 15,447 54 0.35 536 7.85 0.0635
2019-11-15 2019-09-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 15,393 1,240 8.76 497 2.47 0.0676
2019-08-12 2019-06-30 13F INNOVATOR IBD IBD 50 ETF 45782C102 14,153 90 0.64 485 2.97 0.0704
2019-05-16 2019-03-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 14,063 1,675 13.52 471 37.72 0.0785
2019-02-14 2018-12-31 13F INNOVATOR IBD IBD 50 ETF 45782C102 12,388 12,388 342 0.0658
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.